CXCR4, the receptor of stromal cell-derived factor (SDF)-1α, can be induced to overexpress on invading tumor, macrophages/microglia and GSCs in hypoxia-niche, and is a therapeutic target for patients suffering from GBM (Wang et al., 2012). Here, CXCL12 is linked to glioblastoma.